Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase

被引:137
作者
Bullock, AN
Debreczeni, JÉ
Fedorov, OY
Nelson, A
Marsden, BD
Knapp, S [1 ]
机构
[1] Univ Oxford, SGC, Botnar Res Ctr, Oxford OX3 7LD, England
[2] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England
基金
英国工程与自然科学研究理事会; 英国惠康基金;
关键词
D O I
10.1021/jm0504858
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
The kinase PIM-1 plays a pivotal role in cytokine signaling and is implicated in the development of a number of tumors. The three-dimensional structure of PIM-1 is characterized by an unique hinge region which lacks a second hydrogen bond donor and makes it particularly important to determine how inhibitors bind to this kinase. We determined the structures of PIM-1 in complex with bisindolylmaleimide (BIM-1) and established the structure-activity relationship (SAR) for this inhibitor class. In addition, we screened a kinase targeted library and identified a number of high affinity inhibitors of PIM-1 such as imidazo[1,2-b]pyridazines, pyrazolo[1,5a]pyrimidines, and members of the flavonoid family. In this paper we present an initial SAR of the identified scaffolds determined on the basis of a thermostability shift assay, calorimetric binding data, and biochemical assays which may find applications for the treatment of PIM-1 dependent cancer types.
引用
收藏
页码:7604 / 7614
页数:11
相关论文
共 58 条
[1]
BIASED PROBABILITY MONTE-CARLO CONFORMATIONAL SEARCHES AND ELECTROSTATIC CALCULATIONS FOR PEPTIDES AND PROTEINS [J].
ABAGYAN, R ;
TOTROV, M .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (03) :983-1002
[2]
ICM - A NEW METHOD FOR PROTEIN MODELING AND DESIGN - APPLICATIONS TO DOCKING AND STRUCTURE PREDICTION FROM THE DISTORTED NATIVE CONFORMATION [J].
ABAGYAN, R ;
TOTROV, M ;
KUZNETSOV, D .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1994, 15 (05) :488-506
[3]
Akasaka H, 2000, CANCER RES, V60, P2335
[4]
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[5]
Imidazo[1,2-a]pyridines:: A potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation [J].
Anderson, M ;
Beattie, JF ;
Breault, GA ;
Breed, J ;
Byth, KF ;
Culshaw, JD ;
Ellston, RPA ;
Green, S ;
Minshull, CA ;
Norman, RA ;
Pauptit, RA ;
Stanway, J ;
Thomas, AP ;
Jewsbury, PJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :3021-3026
[6]
The serine/threonine kinase pim-1 [J].
Bachmann, M ;
Möröy, T .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (04) :726-730
[7]
Evaluation of alternative approaches for the synthesis of macrocyclic bisindolylmaleimides [J].
Bartlett, S ;
Nelson, A .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (19) :2874-2883
[8]
Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[9]
Imidazo[1,2-b]pyridazines:: a potent and selective class of cyclin-dependent kinase inhibitors [J].
Byth, KF ;
Cooper, N ;
Culshaw, JD ;
Heaton, DW ;
Oakes, SE ;
Minshull, CA ;
Norman, RA ;
Pauptit, RA ;
Tucker, JA ;
Breed, J ;
Pannifer, A ;
Rowsell, S ;
Stanway, JJ ;
Valentine, AL ;
Thomas, AP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2249-2252
[10]
Pim serine/threonine kinases regulate the stability of Socs-1 protein [J].
Chen, XP ;
Losman, JA ;
Cowan, S ;
Donahue, E ;
Fay, S ;
Vuong, BQ ;
Nawijn, MC ;
Capece, D ;
Cohan, VL ;
Rothman, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2175-2180